GPT-Rosalind is OpenAI's first domain-specific model, built for drug discovery and life sciences—and it's not for everyone.

OpenAI rolled out their updated Codex app for Mac yesterday and, among other things, they shipped a native computer use tool ...

Following its recently announced partnership with Novo Nordisk, OpenAI is introducing a new reasoning model, GPT-Rosalind, to ...

Inside OpenAI’s ‘self-operating’ infrastructure, where Codex-powered AI agents debug failures, manage releases, and compress ...

OpenAI on Thursday introduced an artificial intelligence model touting increased biology knowledge and scientific research ...

Rosalind, an AI model designed to accelerate drug discovery and support biology-related research work. Read more here.

OpenAI is framing GPT-Rosalind as a tool to compress the timeline from scientific idea to clinical evidence. The company ...

OpenAI’s upcoming “Spud” model is poised to make a significant impact on the global economy, with its potential to enhance productivity and drive innovation across industries. According to Wes Roth, ...

Open AI CEO Sam Altman speaks during an event in Tokyo, Japan, on Feb. 3, 2025. On Wednesday, OpenAI published a blog post outlining the “philosophy and mechanics" behind its Model Spec—the document ...

Disney, which had inked a major pact for Sora, said it 'will continue to engage with AI platforms to find new ways to meet fans where they are' Disney has now ended its partnership with OpenAI, which ...

OpenAI will soon shut down its Sora AI video-generation app, the company said in a surprising announcement Tuesday. Subscribe to read this story ad-free Get unlimited access to ad-free articles and ...

OpenAI said it will acquire Astral, a startup that builds tools for software developers. Astral's team will join OpenAI as part of the group running its AI coding assistant, Codex. OpenAI has been ...